Checchi Capital Advisers’s Pfizer PFE Stock Holding History

Checchi Capital Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$552K	Sell	22,917 -5,010	-18%	-$131K	0.02%	339
2026 Q1	$784K	Buy	27,927 +5,553	+25%	+$148K	0.04%	257
2025 Q4	$557K	Sell	22,374 -3,839	-15%	-$96.8K	0.03%	291
2025 Q3	$668K	Sell	26,213 -9,011	-26%	-$222K	0.03%	274
2025 Q2	$854K	Buy	35,224 +1,159	+3%	+$27K	0.05%	238
2025 Q1	$863K	Buy	34,065 +2,526	+8%	+$66.1K	0.05%	235
2024 Q4	$837K	Sell	31,539 -10,486	-25%	-$284K	0.05%	225
2024 Q3	$1.22M	Buy	42,025 +1,221	+3%	+$35.6K	0.07%	175
2024 Q2	$1.14M	Sell	40,804 -2,656	-6%	-$73.1K	0.06%	174
2024 Q1	$1.21M	Sell	43,460 -1,176	-3%	-$32.6K	0.09%	172
2023 Q4	$1.29M	Sell	44,636 -10,749	-19%	-$325K	0.1%	156
2023 Q3	$1.84M	Sell	55,385 -7,899	-12%	-$279K	0.17%	110
2023 Q2	$2.32M	Sell	63,284 -4,923	-7%	-$192K	0.21%	93
2023 Q1	$2.78M	Sell	68,207 -458	-0.7%	-$19.8K	0.27%	77
2022 Q4	$3.52M	Sell	68,665 -3,514	-5%	-$168K	0.37%	67
2022 Q3	$3.16M	Buy	72,179 +354	+0.5%	+$17.2K	0.3%	79
2022 Q2	$3.63M	Buy	71,825 +6,595	+10%	+$336K	0.31%	67
2022 Q1	$3.38M	Buy	65,230 +3,333	+5%	+$173K	0.29%	65
2021 Q4	$3.65M	Buy	61,897 +1,407	+2%	+$69.7K	0.32%	62
2021 Q3	$2.6M	Sell	60,490 -3,585	-6%	-$159K	0.26%	68
2021 Q2	$2.51M	Sell	64,075 -2,917	-4%	-$113K	0.25%	76
2021 Q1	$2.43M	Sell	66,992 -1,012	-1%	-$35.9K	0.24%	75
2020 Q4	$2.5M	Sell	68,004 -2,964	-4%	-$109K	0.26%	66
2020 Q3	$2.47M	Sell	70,968 -36	-0.1%	-$1.26K	0.27%	60
2020 Q2	$2.2M	Sell	71,004 -1,549	-2%	-$52.6K	0.26%	58
2020 Q1	$2.25M	Buy	72,553 +4,162	+6%	+$142K	0.22%	49
2019 Q4	$2.54M	Buy	68,391 +1,833	+3%	+$65.3K	0.34%	51
2019 Q3	$2.27M	Sell	66,558 -2,875	-4%	-$105K	0.3%	53
2019 Q2	$2.85M	Sell	69,433 -2,429	-3%	-$96.5K	0.36%	37
2019 Q1	$2.9M	Sell	71,862 -4,620	-6%	-$185K	0.34%	39
2018 Q4	$3.17M	Sell	76,482 -7,448	-9%	-$309K	0.41%	31
2018 Q3	$3.51M	Buy	83,930 +6,811	+9%	+$262K	0.4%	30
2018 Q2	$2.65M	Buy	77,119 +3,972	+5%	+$136K	0.33%	39
2018 Q1	$2.46M	Buy	73,147 +1,389	+2%	+$47.8K	0.32%	39
2017 Q4	$2.47M	Buy	71,758 +2,744	+4%	+$93.6K	0.33%	42
2017 Q3	$2.34M	Sell	69,014 -879	-1%	-$28.3K	0.24%	42
2017 Q2	$2.23M	Sell	69,893 -5,773	-8%	-$182K	0.24%	42
2017 Q1	$2.46M	Sell	75,666 -4,928	-6%	-$155K	0.28%	37
2016 Q4	$2.48M	Buy	80,594 +1,276	+2%	+$39K	0.33%	34
2016 Q3	$2.55M	Buy	79,318 +1,344	+2%	+$44.9K	0.29%	33
2016 Q2	$2.6M	Sell	77,974 -3,023	-4%	-$96.5K	0.3%	27
2016 Q1	$2.28M	Buy	80,997 +4,468	+6%	+$128K	0.51%	30
2015 Q4	$2.34M	Sell	76,529 -2,849	-4%	-$89.6K	0.59%	21
2015 Q3	$2.37M	Buy	79,378 +3,315	+4%	+$106K	0.64%	28
2015 Q2	$2.42M	Buy	76,063 +5,197	+7%	+$169K	0.64%	26
2015 Q1	$2.34M	Buy	70,866 +5,989	+9%	+$190K	0.69%	27
2014 Q4	$1.92M	Buy	64,877 +11,534	+22%	+$331K	0.72%	30
2014 Q3	$1.5M	Buy	53,343 +9,990	+23%	+$280K	0.61%	37
2014 Q2	$1.22M	Buy	43,353 +10,904	+34%	+$311K	0.56%	42
2014 Q1	$989K	Buy	32,449 +6,486	+25%	+$193K	0.61%	41
2013 Q4	$755K	Buy	+25,963	New	+$756K	0.59%	33

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Checchi Capital Advisers's PFE Position: Q2 2026 in Review

Checchi Capital Advisers reduced its Pfizer (PFE) stake by 18% in Q2 2026, selling an estimated $131K and leaving 22,917 shares worth $552K. The position accounts for 0.02% of the portfolio, ranked #339.

Checchi Capital Advisers first reported a position in PFE in Q4 2013 and has held it in 51 quarters since. The position peaked at $3.65M in Q4 2021. 1,939 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Checchi Capital Advisers held 22,917 shares of Pfizer worth $552K as of Q2 2026.
Checchi Capital Advisers sold 5,010 Pfizer shares in Q2 2026, an estimated $131K.
Pfizer made up 0.02% of Checchi Capital Advisers's portfolio in Q2 2026, its #339 holding.
Checchi Capital Advisers first reported a position in Pfizer in Q4 2013 and has held it in 51 quarters since.
Checchi Capital Advisers's Pfizer position peaked at $3.65M in Q4 2021.
1,939 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Checchi Capital Advisers's 13F filing for Q2 2026, filed 4 Aug 2026.